Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04000724 · ClinicalTrials.gov registry record · NA
TechStep: Technology-based Stepped Care to Stem Transgender Adolescent Risk Transmission
A NA study, sponsored by Friends Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 254
- Enrollment target
NCT04000724: Completed NA study, sponsored by Friends Research Institute.
NCT04000724 is a NA study that has completed, run by Friends Research Institute. The registered enrollment target is 254 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04000724, a NA study, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 254 participants
- Enrollment target
Study Summary
TechStep is a three-arm, technology-based randomized controlled trial (RCT), with a stepped care approach, among high-risk HIV-negative transgender feminine, transgender masculine, and gender non-conforming youth and young adults for reducing sexual risk behaviors and increasing pre-exposure prophylaxis (PrEP) uptake. Participants are randomized into one of three conditions for a 6-month intervention: Group 1: culturally relevant theory-based text messages (Text+Step); or, Group 2: culturally relevant mobile-enhanced website (WebApp+Step); or, Group 3: informational website control condition with no theoretically based text messages or WebApp.
Primary Outcome
Participants will report the frequency of condomless sexual intercourse events they have engaged in for the past 3 months at baseline and at each follow-up. The value of interest is the cumulative number of events over follow-up.
Interventions
- BEHAVIORAL Text Messaging (Text+Step)
- BEHAVIORAL WebApp (App+Step)
- BEHAVIORAL Information/No Step
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2019-10-18 |
| Est. Completion | 2022-05-31 |
| Phase | NA |
What the finished NCT04000724 record still lists
NCT04000724 is an interventional study that assigns participants to a tested intervention. The registered 254 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 3 interventions - of which Text Messaging (Text+Step) is the first listed.
NCT04000724 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04000724 about?
NCT04000724 is a clinical study titled "TechStep: Technology-based Stepped Care to Stem Transgender Adolescent Risk Transmission". TechStep is a three-arm, technology-based randomized controlled trial (RCT), with a stepped care approach, among high-risk HIV-negative transgender feminine, transgender masculine, and gender non-conforming youth and young adults for reducing sexual risk behaviors and increasing pre-exposure prophyl...
What is the current status of trial NCT04000724?
This trial is currently completed. It is a NA study. The enrollment target is 254 participants. The study started on 2019-10-18. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT04000724?
The interventions under investigation include: Text Messaging (Text+Step) (BEHAVIORAL), WebApp (App+Step) (BEHAVIORAL), Information/No Step (BEHAVIORAL).
Who is sponsoring clinical trial NCT04000724?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04000724's enrollment target sits among peer trials
254 407th of 2000 higher than 1,594 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI